Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

Why did UnitedHealth’s stock plunge recently? How are Trump’s tariffs impacting U.S. retailers? What caused Nvidia CEO to call chip export policy a failure? Why is Target cutting its sales outlook? How is Bitcoin reaching new all-time highs? What’s the effect of rising U.S. Treasury yields on stocks? Why did OpenAI buy Jony Ive’s hardware startup? How are AI advancements reshaping business strategies? What’s behind Walmart’s response to Trump’s tariffs?

Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

benzinga.com/general/biotech/25/05/45540026/exclusive-telomir-pharma-to-raise-3-million-via-equity-financing-to-fund-its-rare-disease-ind

On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced that it had secured $3 million in equity financing through a direct investment by The Bayshore Trust, the company's largest shareholder.
The transaction involved the purchase of 1 million restricted shares of the…

This story appeared on benzinga.com, 2025-05-21 12:15:00.